TY  - JOUR
AU  - Debruyne, Frans M J
AU  - Behre, Hermann M
AU  - Roehrborn, Claus G
AU  - Maggi, Mario
AU  - Wu, Frederick C W
AU  - Schröder, Fritz H
AU  - Jones, Thomas Hugh
AU  - Porst, Hartmut
AU  - Hackett, Geoffrey
AU  - Wheaton, Olivia A
AU  - Martin-Morales, Antonio
AU  - Meuleman, Eric
AU  - Cunningham, Glenn R
AU  - Divan, Hozefa A
AU  - Rosen, Raymond C
AU  - RHYME Investigators
PY  - 2016
DO  - 10.1111/bju.13578
UR  - http://hdl.handle.net/10668/10263
T2  - BJU international
AB  - To evaluate the effects of testosterone-replacement therapy (TRT) on prostate health indicators in hypogonadal men, including rates of prostate cancer diagnoses, changes in prostate-specific antigen (PSA) levels and lower urinary tract symptoms (LUTS)...
LA  - en
KW  - #PCSM
KW  - #ProstateCancer
KW  - benign prostatic hyperplasia
KW  - disease registry
KW  - hypogonadism
KW  - testosterone
KW  - Disease Progression
KW  - Hormone Replacement Therapy
KW  - Humans
KW  - Hypogonadism
KW  - Lower Urinary Tract Symptoms
KW  - Male
KW  - Middle Aged
KW  - Prostate-Specific Antigen
KW  - Prostatic Neoplasms
KW  - Registries
KW  - Risk Assessment
KW  - Testosterone
TI  - Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
TY  - research article
VL  - 119
ER  -